Synergistic effects of interleukin-1β, interleukin-6, and tumor necrosis factor-α: Central monoamine, corticosterone, and behavioral variations

Neuropsychopharmacology

Volumn 22, Issue 6, 2000, Pages 566-580

  Brebner, Karen ^a,b   Hayley, Shawn ^a,b   Zacharko, Robert ^a   Merali, Znl ^b   Anisman, Hymie ^a  

^a CARLETON UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Corticosterone; Cytokines; Dopamine; IL 1; IL 6; Monoamines; Neurochemical; Norepinephrine; Serotonin; Synergism; TNF

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; BRAIN MONOAMINE; CORTICOSTERONE; CYTOKINE; DOPAMINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; NORADRENALIN; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA;

AMINE TRANSPORT; ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY NEUROSIS; ARTICLE; BEHAVIOR; CACAO; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; HORMONE BLOOD LEVEL; LOCUS CERULEUS; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; BRAIN; CORTICOSTERONE; EATING; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MICE; MICE, INBRED STRAINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034008318     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00166-9     Document Type: Article

References (81)

1. Abercrombie ED, Jacobs BL (1987): Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. I. Acutely presented stressful and nonstressful stimuli. J Neurosci 9:2837-2843
2. Alonso R, Chaudieu I, Diorio J, Krishnamurthy A, Quirion R, Boksa P (1993): Interleukin-2 modulates evoked release of [3H]dopamine in rat cultured mesencephalic cells. J Neurochem 61:1284-1290
3. Anisman H, Merali Z (1999): Cytokines and stress in relation to anxiety and anhedonia. In Dantzer R, Wollman EE, Yirmiya R (eds), Cytokines, Stress and Depression. New York, Plenum Press
4. Anisman H, Ravindran AV, Griffiths J, Merali Z (1998): Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol Psychiatry 4:182-188
5. Berenbaum MC (1989): What is synergy? Pharmacol Rev 41:93-141
6. Blalock JE (1994): The syntax of immune-neuroendocrine communication. Immunol Today 15:504-511
7. Bluthe RM, Dantzer R, Kelley KW (1992): Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in the rat. Brain Res 575:318-320
8. Bluthe RM, Pawlowski M, Suarez S, Parnet P, Pittman Q, Kelley KW, Dantzer R (1994): Synergy between tumor necrosis factor-a and interleukin-1 in the induction of sickness behavior in mice. Psychoneuroendocrinology 19:197-207
9. Borowski T, Kokkinidis L, Merali Z, Anisman H (1998): Lipopolysaccharide, central in vivo amine alterations, and anhedonia. NeuroReport 9:3797-3802
10. Brouckaert PG, Everaerdt B, Libert C, Takahashi N, Fiers W (1989a): Species specificity and involvement of other cytokines in endotoxin shockaction of recombinant tumor necrosis factor in mice. Agents Actions 26:196198
11. Brouckaert PG, Libert C, Everaerdt B, Takahashi N, Fiers W (1989b): A role for interleukin-1 in the in vivo actions of tumor necrosis factor. Lymphok Res 8:269-274
12. Capuron L, Ravaud A, Radat F, Dantzer R, Goodall G (1998): Affects of interleukin-2 and alpha-interferon cytokine immunotherapy on the mood and cognitive performance of cancer patients. Neuroimmunomodulation 5:9
13. Caraceni A, Martini C, Belli F, Mascheroni L, Rivoltini L, Arienti F, Cascinelli N (1992): Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration. Eur J Cancer 29A:1266-1269
14. Chiueh CC, Zukowska-Grojec Z, Kirk KL, Kopin JJ (1983): 6fluorocatechaolamine as a false adrenergic neurotransmitter. J Pharmac Exp Ther 225:529-533
15. Connor TJ, Song C, Leonard BE, Merali Z, Anisman H (1998): An assessment of the effects of central interleukin-l, -2, -6 and tumor necrosis factor-a administration on some behavioral, neurochemical, endocrine and immune parameters in the rat. Neuroscience 84:923-933
16. Cunningham ET Jr, Sawchenko PE (1988): Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol 274:60-76
17. Dantzer R, Bluthe RM, Auber A, Goodall G, Bret-Dibat JL, Kent S, Goujon E, Laye S, Parnet P, Kelley KW (1996): Cytokine actions on behavior. In Rothwell NJ (ed), Cytokines and the Nervous System. London, Landes, pp 117-144
18. Denicoff KD, Rubinow DR, Papa MZ, Simpson L, Seipp LA, Lotze MT, Chang AE, Rosenstein D, Rosenberg SA (1987): The neuropsychiatrie effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Int Med 107:293-300
19. Dinan T (1996): Serotonin and the regulation of hypothalamicpituitary-adrenal axis function. Life Sei 58:1683-1694
20. Dünn AJ (1988): Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism paral-leling the increased plasma corticosteronc. Life Sei 43:429-435
21. Dünn A] (1990): Interleukin-1 as a stimulator of hormone secretion. Prog Neurol Endocrinol Immunol 3:26-34
22. Dunn AJ (1992a): The role of interleukin-1 and tumor necrosis factor alpha in the neurochemical and neuroendocrine responses to endotoxin. Brain Res Bull 6:807-812
23. Dunn AJ (1992b): Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: Comparison with interleukin-1. J Pharmac Exp Ther 261:964-969
24. Ebisui O, Fukata J, Murakami N, Kobayashi H, Segawa H, Muro S, Hanaoka I, Naito Y, Masui Y, Ohmoto Y, Imura H, Nakao K (1994): Effect of IL-1 receptor antagonist and antiserum to TNF-a on LPS-induced plasma ACTH and corticosterone rise in rats. Am] Physiol 266:E986-E992
25. Elenkov IJ, Kovacs K, Duda E, Stark E, Vizi ES (1992): Presynaptic inhibitory effect of TNF-alpha on the release of noradrenaline in isolated median eminence. ] Neuroimmunol 41:117-120
26. Everaerdt B, Brouckaert PG, Shaw A, Fiers W (1989): Four different interleukin-1 species sensitize to the lethal action of tumor necrosis factor. Biochem Biophys Res Commun 163:378-385
27. Feldman S, Conforti N, Melamed E (1987): Paraventricular nucleus serotonin mediates neurally stimulated adrenocortical secretion. Brain Res Bull 18:165-168
28. Franklin KBJ, Paxinos G (1997): The Mouse Brain in Stereotaxic Coordinates. San Diego, Plenum
29. Gann DS, Ward DG, Baertschi AJ, Carlson DE, Maran JW (1977): Neural control of ACTH release in response to hemorrage. Ann NY Acad Sei 297:477-497
30. Gayle D, Ilyin SE, Miele ME, Plata-Salaman C (1998): Modulation of TNF-alpha mRNA production in rat C6 glioma cells by TNF-alpha, IL-lbeta, IL-6, and IFN-alpha: In vitro analysis of cytokine-cytokine interactions. Brain Res Bull 47:231-235
31. Hayley S, Brebner K, Lacosta S, Merali Z, Anisman H (1999): Sensitization to the effects of tumor necrosis factor-a; Neuroendocrine, central monoamine and behavioral variations. J Neurosci 19:5654-5665
32. Herman JP, Cullinan WE (1997): Neurocircuitry of stress: Central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20:78-84
33. Hopkins SJ, Rothwell NJ (1995): Cytokines and the nervous system. I. Expression and recognition. Trends Neurosci 18:83-88
34. Ignatowski TA, Spengler RN (1994): Tumor necrosis factorex: Presynaptic sensitivity is modified after antidepressant drug administration. Brain Res 665:293-299
35. Jeohn GH, Kong LY, Wilson B, Hudson P, Hong JS (1998): Syergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J Neuroimmunol 85:1-10
36. Johnson RW, Propes MJ, Shavit Y (1996): Corticosterone modulates behavioral and metabolic effects of lipopolysacchnride. Am J Physiol 270:R192-R198
37. Kakucksa I, Qi Y, Clark BD, Lechan RM (1993): Endotoxininduced corticotropin-releasing hormone gene expression in the paraventricular nucleus is mediated by interleukin-1. Endocrinology 133:815-821
38. Kent S, Bret-Dibat JL, Kelley KW, Dantzer R (1996): Mechanisms of sickness induced decreases in food-motivated behavior. Neurosci Biobehav Rev 20:171-175
39. Korte SM, Van Dunn S, Bouws GA, Koolhaas JM, Bohus B (1991): Involvement of hypothalamic serotonin in activation of the sympathoadrenomedullary system hypothalamo-pituitary-adrenocortical axis in male wistar rats. Eur J Pharmacol 197:225-228
40. Kuemmerle JF (1998): Synergistic regulation of NOS II expression by IL-1 beta and TNF-alpha in cultured rat colonie smooth muscle cells. Am J Physiol 274:G178-G185
41. Lacosta S, Merali Z, Anisman H (1999): Behavioral and neurochemical consequences of lipopolysaccharide in mice: Anxiogenic-like effects. Brain Res 818:291-303
42. Lacosta S, Merali Z, Anisman H (1998): Influence of interleukin-lbeta on exploratory behaviors, plasma ACTH, corticosterone, and central biogenic amines in mice. Psychopharmacology 137:351-361
43. Lapchak PA (1992): A role for IL-2 in the regulation of striatal dopaminergic function. NeuroReport 3:165-168
44. Linthorst AC, Reul JM (1998): Brain neurotransmission during peripheral inflammation. Ann NY Acad Sei 840:139-152
45. Linthorst ACE, Flachskamm C, Muller-Preuss P, Holsboer F, Reul JMHM (1995): Effect of bacterial endotoxin and interleukin-l on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: An in vivo microdialysis study. J Neurosci 15:2920-2934
46. Long NC, Otterness I, Kunkel SL, Vander A], Kluger MJ (1990): Roles of inteleukin-l and tumor necrosis factor in lipopolysaccharide fever in rats. Am J Physiol 259:R724-R728
47. Lu G, Beuerman RW, Zhao S, Sun G, Nguyen DH, Ma S, Kline, DG (1997): Tumor necrosis factor-alpha and interleukin-1 induce activation of MAP kinase and SAP kinase in human nueroma fibroblasts. Neurochem Intl 30:401-410
48. Macs M (1995): Evidence for an immune response in major depression: A review and hypothesis. Prog Neuro-Psychopharmacol Biol Psychiatry 19:11-38
49. Maes M, Meltzer HY, Bosnians E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R (1995): Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 34:301-309
50. Maier SF, Watkins LR (1998): Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 105:83-107
51. Masana MI, Heyes MP, Mefford IN (1990): Indomethacin prevents increased catecholamine turnover in rat brain following systemic endotoxin challenge. Prog NeuroPsychopharmacol Biol Psychiatry 14:609-621
52. Malta SG, Weatherbee J, Sharp BM (1992): A central mechanism is involved in the secretion of ACTH in response to IL-6 in rats: Comparison to and interaction with ILl. Neuroendocrinology 56:516-525
53. Mefford IN, Masters CF, Heyes MP, Eskay RL (1991): Cytokine-induced activation of the neuroendocrine stress axis persists in endotoxin-tolerant mice. Brain Res 557:327-330
54. Merali Z, Lacosta S, Anisman H (1997): Effects of interleukin-lbeta and mild stress on alterations of norepinephrine, dopamine and serotonin neurotransmission: A regional microdialysis study. Brain Res 761:225-235
55. Meyers CA, Valentine AD (1995): Neurological and psychiatric adverse effects of immunological therapy. CNS Drugs 3:56-68
56. Mino T, Sugiyama E, Taki H, Kuroda A, Yamashita N, Maruyama M, Kobayashi M (1998): Interleukin-lalpha and tumor necrosis factor alpha syergistically stimulate prostaglandin E2-dependent production of interleukin11 in rheumatoid synovial fibroblasts. Arthritis Rheum 41:2004-2013
57. Muller N, Ackenheil M (1998): Psychoneuroimmunology and the cytokine action in the CNS: Implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 22:1-33
58. O'Reilly B, Vander AJ, Kluger MJ (1987): Effects of chronic infusion of lipopolysaccharide on food intake and body temperature of the rat. Physiol Behav 42:287-291
59. Palazzolo DL, Quadri SK (1992): Interleukin-1 inhibits serotonin release from the hypothalamus in vitro. Life Sei 51:1797-1802
60. Perlstein RS, Moughey EH, Jackson WE, Neta R (1991): Interleukin-1 and interleukin-6 act synergistically to stimulate the release of adrenocorticotropic hormone in vivo. Lymphok Cytok Res 10:141-146
61. Plata-Salaman CR (1988): Food intake suppression by imunomodulators. Neurosci Res Comm 3:159-165
62. Plata-Salaman CR, Oomura Y, Kai Y (1988): Tumor necrosis factor and interleukin-l: Suppression of food intake by direct action in the central nervous system. Brain Res 448:106-114
63. Plata-Salaman CR, Sonti G, Borkoski JP, Wilson CD, FfrenchMullen JMH (1996): Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations. Physiol Behav 60:867-875
64. Rivier C (1993): Effect of perhiperal and central cytokines on the hypothalamic-pituitary-adrenal axis of the rat. Ann NY Acad Sei 697:97-105
65. Rothwell NJ, Allan S, Toulmond S (1997): The role of interleukin-1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J Clin Invest 100:2648-2652
66. Seegal RF, Bosh KO, Bush B (1986): High performance liquid chromatography of biogenic amines and metabolites in the brain, cerebrospinal fluid, urine and plasma. J Chromatogr 377:131-144
67. Shintani F, Kanba S, Nakaki T, Nibuya M, Kinoshita N, Suzuki E, Yagi G, Kato R, Asai M (1993): Interleukin-l augments release of norepinephrine, dopamine and serotonin in the rat anterior hypothalamus. J Neurosci 13:3574-3581
68. Shintani F, Nakaki T, Kanba S, Sato K, Yagi G, Shiozawa M, Asio S, Kato R, Asai M (1995): Involvement of interleukin-1 immobilization stress-induced increase in adrenocorticotropic hormone and in the release of hypothalamic monoamines in the rat. J Neurosci 15:1961-1970
69. Song C, Merali Z, Anisman H (1999): Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment. Neuroscience 88:823-836
70. Sonti G, Ilyin SE, Plata-Salaman C (1996): Anorexia induced by cytokine interactions at pathophysiological concentrations. Am J Physiol 270:R1394-R1402
71. Terao A, Oikawa M, Saito M (1993): Cytokine-induced change in hypothalamic norepinephrine turnover: Involvement of corticotropin-releasing hormone and prostaglandins. Brain Res 622:257-261
72. Tilders JJH, DeRijk RH, Van Dam AM, Vincent VAM, Schotanus K, Persoons JHA (1993): Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: Routes and intermediate signals. Psychoneuroendocrinology 19:209-232
73. Van der Meer MJM, Sweep CGJF, Pesman GJ, Borm GF, Hermus RMM (1995): Synergism between IL-l and TNF-a on the activity of the pituitary adrenal axis and on food intake of rats. Am J Physiol 268:E551-E557
74. Vogel SN, Henricson BE, Neta R (1991): Roles of interleukin and tumor necrosis factor in lipopolysaccharide-induced hypoglycemia. Brain Behav Immun 59:2494-2498
75. Wang J, Dünn AJ (1999): The role of interleukin-6 in the activation of the hypothalamo-pituitary-adrenocortical axis and brain indoleamines by endotoxin and interleukin-1 beta. Brain Res 815:237-248
76. Weiss JM (1991): Stress induced depression: Critical neurochemical and electrophysiological changes. In Madden J (ed), Neurobiology of Learning, Emotion and Affect. New York, Raven Press
77. Whitnall MH (1993): Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog Neurobiol 40:573-629
78. Yang Z, Koseki M, Meguid MM, Gleason JR, Debonis D (1994): Synergistic effect of rhTNF-a and rhIL-la in inducing anorexia in rats. Am J Physiol 267:R1056-R1064
79. Zalcman S, Green-Johnson JM, Murray L, Nance DM, Dyck D, Anisman H, Greenberg A (1994): Cytokine-specific central monoamine alterations induced by interleukin (IL)-l, IL-2 and IL-6. Brain Res 643:40-49
80. Zanetti G, Heusmann D, Gerain J, Kohler J, Abbet P, Barras C, Lucas R, Glauser M, Baumgartner J (1992): Cytokine production after intravenous or peritoneal gram negative bacterial challenge in mice. J Immunol 6:1890-1897
81. Zhou D, Shanks N, Riechman SE, Liang R, Kusnecov AW, Rabin BS (1996): Interleukin 6 modulates interleukin-1 and stress-induced activation of the hypothalamic-pituitary-adrenal axis in male rats. Neuroendocrinology 63:227-236